7–11 Oct 2024
Almaty, Kazakhstan
Asia/Almaty timezone

JUSTIFICATION OF 75SE AND 169Y AS SOURCES FOR KILOVOLTAGE X-RAY THERAPY WITH RADIOSENSITIZERS

Not scheduled
20m
Almaty, Kazakhstan

Almaty, Kazakhstan

The library building of the Al-Farabi Kazakh National University 71/27 Al-Farabi Avenue
Sub-Section 4-1 “Nuclear Medicine”

Speaker

Dr Gayana Abdullaeva (Institute of Nuclear Physics, Academy of Sciences of Uzbekistan, Tashkent)

Description

JUSTIFICATION OF 75Se AND 169Y AS SOURCES FOR KILOVOLTAGE X-RAY THERAPY WITH RADIOSENSITIZERS

G. A. Abdullaeva, G. A. Kulabdullaev, E. X. Normatov

Institute of Nuclear Physics, Academy of Sciences of the Republic of Uzbekistan, Tashkent

Kilovoltage x-rays have been used for the treatment of cancer alongside MV x-rays for decades. For treatments of deep-seated tumors, a number of challenges for kV therapy compared to MV therapy exist, such as the increased treatment time, dose calculation complexity, potential differences in radiobiology between kV and MV beams. Due to the increased probability of photo-electric interactions, kV x-ray beams have the potential to increase radiation dose to a target loaded with x-ray contrast agents of high atomic number (Z).
Current research is aimed at the study of the effects of X-ray radiation on brain tumors in presence contrast agents, as well as the physical mechanisms. So justification of 75Se and 169Y as sources for kilovoltage X-ray therapy with radiosensitizers are presented.

Section 4th International Conference “Nuclear and Radiation Technologies in Medicine, Industry and Agriculture” (Section 4)

Primary author

Dr Gayana Abdullaeva (Institute of Nuclear Physics, Academy of Sciences of Uzbekistan, Tashkent)

Co-authors

Gayratulla Kulabdullaev (Institute of Nuclear Physics of Academy of Sciences of Uzbekistan) Mr Eshpulat Normatov (Institute of Nuclear Physics, Academy of Sciences of the Republic of Uzbekistan)

Presentation materials